Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Treace Medical Concepts (TMCI) FCF Margin (2020 - 2025)

Treace Medical Concepts (TMCI) has disclosed FCF Margin for 6 consecutive years, with 16.67% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, FCF Margin fell 608.0% year-over-year to 16.67%, compared with a TTM value of 13.86% through Dec 2025, up 943.0%, and an annual FY2025 reading of 13.86%, up 943.0% over the prior year.
  • FCF Margin was 16.67% for Q4 2025 at Treace Medical Concepts, up from 23.7% in the prior quarter.
  • Across five years, FCF Margin topped out at 1.25% in Q1 2025 and bottomed at 52.64% in Q2 2022.
  • Average FCF Margin over 5 years is 24.45%, with a median of 22.76% recorded in 2024.
  • The sharpest move saw FCF Margin tumbled -3122bps in 2022, then surged 2306bps in 2025.
  • Year by year, FCF Margin stood at 13.91% in 2021, then decreased by -11bps to 15.45% in 2022, then skyrocketed by 82bps to 2.76% in 2023, then tumbled by -284bps to 10.6% in 2024, then crashed by -57bps to 16.67% in 2025.
  • Business Quant data shows FCF Margin for TMCI at 16.67% in Q4 2025, 23.7% in Q3 2025, and 16.5% in Q2 2025.